The effects of different hormone treatment on endothelial function in healthy postmenopausal women

References

• Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–10
   PubMed Web of Science ®Google Scholar
• Herrington DM, Espeland MA, Crouse JR 3rd, et al. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol 2001;21:1955–61
   PubMed Web of Science ®Google Scholar
• Vita JA, Keany JF. Hormone replacement therapy and endothelial function. The exception that proves the rule? Arterioscler Thromb Vasc Biol 2001;21:1867–9
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115–26
   PubMed Web of Science ®Google Scholar
• Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899–906
   PubMed Web of Science ®Google Scholar
• Henderson A. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol 1997;62:43–8
   Google Scholar
• Celermajer DS, Sorenson KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111–5
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235–41
   PubMed Web of Science ®Google Scholar
• Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257–65
   PubMed Web of Science ®Google Scholar
• Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004;89:3907–13
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women’s Health Initative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605–13
   PubMed Web of Science ®Google Scholar
• Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:27–32
   Web of Science ®Google Scholar
• Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997;303:25–53
   Google Scholar
• Koh KK, Jin DK, Yang SH, et al. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal woman. Circulation 2001;103:1961–6
   PubMed Web of Science ®Google Scholar
• Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T. Effect of medroxyprogesterone asetate on endotehelium-dependent vasodilation in postmenopausal woman receiving estrogen. Circulation 2001;104:1773–8
   PubMed Web of Science ®Google Scholar
• Gisclard V, Miller VM, Vanhoutte P. Effect of 17alfa-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988;244:19–22
   PubMed Web of Science ®Google Scholar
• Arnal JF, Clamens S, Pechet C, et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine aortic endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996;93:4108–13
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME. Mechanisms of estrogen action in the cardiovascular system. J Steroid Biochem Mol Biol 2000;74:337–43
   PubMed Web of Science ®Google Scholar
• Reslan OM, Khalil RA. Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials 2012;7:47–70
   PubMedGoogle Scholar
• Denti L. The hormone replacement therapy (HRT) of menopause: focus on cardiovascular implications. Acta Biomed 2010;81:73–6
   Google Scholar
• McCrohon JA, Adams MR, McCredie RJ, et al. Hormone replacement therapy is associated with improved arterial physiology in healty post-menopausal woman. Clin Endocrinol 1996;45:435–41
   PubMed Web of Science ®Google Scholar
• Gerhard M, Walsh BW, Tawakol A, et al. Estrodiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal woman. Circulation 1998;98:1158–63
   PubMed Web of Science ®Google Scholar
• L’Hermite M, Simoncini T, Fuller S, Genazzani AR. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas 2008;60:185–201
   PubMed Web of Science ®Google Scholar
• Simoncini T, Caruso A, Giretti MS, et al. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil Steril 2006;86:1235–42
   PubMed Web of Science ®Google Scholar
• Simoncini T, Mannella P, Fornari L, et al. Differential signal transduction of progesterone andmedroxyprogesterone acetate in human endothelial cells. Endocrinology 2004;145:5745–56
   PubMed Web of Science ®Google Scholar
• Simoncini T, Mannella P, Fornari L, et al. Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab 2004;89:4594–600
   PubMed Web of Science ®Google Scholar
• Seeger H, Kloosterboer HJ, Studen M, et al. In vitro effects of tibolone and its metabolites on human vascular coronary cells. Maturitas 2007;58:42–9
   Google Scholar
• Koh KK, Ahn JY, Jin DK, et al. Significant differential effects of hormone therapy or tibolone onmarkers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study. Arterioscler Thromb Vasc Biol 2003;23:1889–94
   PubMed Web of Science ®Google Scholar
• Koh KK, Han SH, Shin MS, et al. Significant differential effects of lower doses of hormone therapy or tibolone on markers ofcardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study. Eur Heart J 2005;26:1362–8
   PubMed Web of Science ®Google Scholar
• de Kleijn MJ, Wilmink HW, Bots ML, et al. Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women. Atherosclerosis 2001;159:357–65
   PubMed Web of Science ®Google Scholar
• Silvestri A, Gambacciani M, Vitale C, et al. Different effect of hormone replacementtherapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk. Maturitas 2005;50:305–11
   PubMed Web of Science ®Google Scholar
• Sarrel PM, Haq N, Wendy C, et al. Raloxifene and endothelial function in healthy postmenopausal woman. Am J Obstet Gynecol 2002;188:304–9
   Google Scholar
• Saitta A, Altavilla D, Cucinotta D, et al. Randomized, double-blind, placebo-controlled study on effects of raloxifenee and hormone replacement therapy on plasma NO concentratations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal woman. Arterioscler Thromb Vasc Biol 2001;21:1512–9
   PubMed Web of Science ®Google Scholar
• Simoncini T, Genazzani AR. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J Clin Endocrinol Metab 2000;85:2966–669
   PubMed Web of Science ®Google Scholar
• Simoncini T, Genazzani AR, Liao JK. Nongenomic mechanisms of endothelialnitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 2002;105:1368–73
   PubMed Web of Science ®Google Scholar
• Dushek EJJ, Stehouwer CDA, De Valk-De Roo GW, et al. Raloxifene, conjugated oestrogen and endotheilial function in postmenopausal woman. J Intern Med 2003;254:85–94
   Google Scholar
• Bechlioulis A, Naka KK, Kalantaridou SN, et al. Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: potential role of estrogen receptor polymorphisms. Maturitas 2012;71:389–395
   PubMed Web of Science ®Google Scholar
• Henmi N, Takahashi K, Amita M, et al. Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women. Menopause 2010;17:615–21
   Google Scholar